The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Gilead Sciences; GlaxoSmithKline; MSD; Roche
Consulting or Advisory Role - GlaxoSmithKline; MSD
Vibostolimab coformulated with pembrolizumab (vibo/pembro) for previously treated advanced mismatch repair–deficient (dMMR) endometrial cancer: Results from cohort B1 of the phase 2 KEYVIBE-005 study.
 
Carlos Rojas
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Knight Therapeutics/Biotoscana; Merck Sharp & Dohme; Pfizer; Roche
Research Funding - AstraZeneca; Bristol-Myers Squibb/Celgene; Knight Therapeutics/Biotoscana; Merck; Pfizer; Roche
Expert Testimony - AstraZeneca; Bristol-Myers Squibb; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Ferry Eskens
No Relationships to Disclose
 
François Ghiringhelli
Honoraria - roche
Research Funding - AstraZeneca/MedImmune (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Roche/Genentech; Roche/Genentech
 
Mustafa Özgüroğlu
Honoraria - Astellas Pharma; Janssen Oncology (Inst); Novartis
Consulting or Advisory Role - AstraZeneca; MSD Oncology
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Christian Caglevic
Consulting or Advisory Role - Gilead Sciences
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Athenex (Inst); Bayer HealthCare Pharmacuticals (Inst); BioNTech SE (Inst); Bristol-Myers Squibb (Inst); Cogent Biosciences (Inst); daiichi Sankyo INC (Inst); Dizal Pharma (Inst); Exelixis (Inst); F. Hoffmann LaRoche (Inst); GlaxoSmithKline (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Sanofi (Inst); Zymeworks (Inst)
 
Mahmut Gumus
Honoraria - GlaxoSmithKline (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst)
Consulting or Advisory Role - Amgen (Inst); Gen (Inst); Gilead Sciences (Inst); Lilly (Inst); Novartis (Inst); Roche; Takeda (Inst)
Speakers' Bureau - Amgen (Inst); MSD Oncology (Inst); Novartis (Inst); Polipharma (Inst); Roche (Inst)
Research Funding - Amgen (Inst); MSD Oncology (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Diego Tosi
Consulting or Advisory Role - Mabqi (Inst); Medesis Pharma (I); Vertical (Inst)
Research Funding - Bayer; Ipsen
Patents, Royalties, Other Intellectual Property - I have a pending patent on a new drug combination for prostate cancer treatment
Travel, Accommodations, Expenses - Advanced Accelerator Applications; AstraZeneca; BMS; Ipsen; Janssen; Nutricia (I); Pfizer
(OPTIONAL) Uncompensated Relationships - Brenus Pharma; Phost'in
 
Julien Grenier
Honoraria - Daiichi Sankyo; Gilead Sciences
Travel, Accommodations, Expenses - Daiichi Sankyo; Gilead Sciences; Lilly
 
Alejandro Falcon Gonzalez
Consulting or Advisory Role - AstraZeneca; Pfizer; Roche/Genentech; Steve
Speakers' Bureau - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Eisai; Grunenthal; Lilly; Novartis; Pfizer; Roche/Genentech; Seagen
 
Andres Arenas
No Relationships to Disclose
 
Lucia Gonzalez-Cortijo
No Relationships to Disclose
 
Andrew George Robinson
Honoraria - Merck
Consulting or Advisory Role - Amgen; AstraZeneca; Merck
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Roche Canada (Inst)
 
Javier Cuello
No Relationships to Disclose
 
Maria C Bell
No Relationships to Disclose
 
Mariusz Kwiatkowski
No Relationships to Disclose
 
Mehmet Ali Nahit Sendur
Honoraria - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Janssen; MSD; Novartis; Pfizer; Roche; Takeda
Speakers' Bureau - Abdi Ibrahim; Abdi Ibrahim; Amgen; Astellas Pharma; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Roche; Takeda
 
Qi Liu
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck
 
Tanya Elizabeth Keenan
Employment - 5AM Ventures (I); Merck
 
Jane Anne Healy
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Robin Guo
Research Funding - AstraZeneca (Inst); Merck (Inst); Prelude Therapeutics (Inst)